Skip to main content
Top
Published in: European Radiology 7/2013

01-07-2013 | Interventional

Temporary stent placement with concurrent chemoradiation therapy in patients with unresectable oesophageal carcinoma: is there an optimal time for stent removal?

Authors: Jung-Hoon Park, Ho-Young Song, Ju Yang Park, Jin Hyoung Kim, Yong Hee Kim, Jong-Hoon Kim, Sung-Bae Kim

Published in: European Radiology | Issue 7/2013

Login to get access

Abstract

Objective

To investigate the influence of the timing of stent removal on the outcome of temporary stent placement with concurrent chemoradiation therapy in patients with unresectable oesophageal carcinoma.

Methods

Retrospective analysis was performed on 52 patients undergoing temporary stent placement. Stents were electively removed within 4 weeks in 15 patients (group A), 4–6 weeks in 17 patients (group B) and after 6 weeks in 20 patients (group C). Recurrent symptoms after stent removal, dysphagia score and overall survival periods were compared among the groups.

Results

Stent placement and removal were technically successful in all patients. The dysphagia score was significantly improved in all groups (P < 0.001). In 19 patients (36 %), recurrent symptoms occurred 15–441 days after stent removal. In group A, recurrent obstruction was significantly higher than in groups B (P = 0.049) and C (P = 0.019). Incidence of oesophago-respiratory fistulas in group C was significantly higher than in group A (P = 0.027). There was no significant difference in survival periods.

Conclusion

The ideal time for stent removal likely falls between 4 and 6 weeks following the start of palliative CCRT allowing the temporary stents to relieve dysphagia effectively in patients with unresectable oesophageal carcinoma.

Key Points

Stents are usually required for unresectable oesophageal carcinoma
Optimal timing of stent removal is 4–6 weeks after starting palliative CCRT.
Early stent removal (<4 weeks) is associated with higher recurrence rates.
Delayed stent removal (>6 weeks) is associated with greater oesophago-respiratory fistula development.
Literature
1.
go back to reference Song HY, Lee DH, Seo TS et al (2002) Retrievable covered nitinol stents: experiences in 108 patients with malignant esophageal strictures. J Vasc Interv Radiol 13:285–292PubMedCrossRef Song HY, Lee DH, Seo TS et al (2002) Retrievable covered nitinol stents: experiences in 108 patients with malignant esophageal strictures. J Vasc Interv Radiol 13:285–292PubMedCrossRef
2.
go back to reference Adler DG, Fang J, Wong R et al (2009) Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy. Gastrointest Endosc 70:614–619PubMedCrossRef Adler DG, Fang J, Wong R et al (2009) Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy. Gastrointest Endosc 70:614–619PubMedCrossRef
3.
go back to reference Siersema PD, Hop WC, van Blankenstein M et al (2000) A new design metal stent (Flamingo stent) for pallication of malignant dysphagia: a prospective study. Gastrointest Endosc 51:139–145PubMedCrossRef Siersema PD, Hop WC, van Blankenstein M et al (2000) A new design metal stent (Flamingo stent) for pallication of malignant dysphagia: a prospective study. Gastrointest Endosc 51:139–145PubMedCrossRef
4.
go back to reference Langer FB, Schoppmann SF, Prager G et al (2010) Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol 17:470–475PubMedCrossRef Langer FB, Schoppmann SF, Prager G et al (2010) Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol 17:470–475PubMedCrossRef
5.
go back to reference Caspers RJ, Welvaart K, Verkes RJ et al (1988) The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. Radiother Oncol 12:15–23PubMedCrossRef Caspers RJ, Welvaart K, Verkes RJ et al (1988) The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. Radiother Oncol 12:15–23PubMedCrossRef
6.
go back to reference Shin JH, Song HY, Kim JH et al (2005) Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinoma. J Vasc Interv Radiol 16:67–74PubMedCrossRef Shin JH, Song HY, Kim JH et al (2005) Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinoma. J Vasc Interv Radiol 16:67–74PubMedCrossRef
7.
go back to reference Song HY, Jung HY, Park SI et al (2000) Covered retrievable expandable nitinol stents in patients with benign esophageal strictures: initial experience. Radiology 217:551–557PubMed Song HY, Jung HY, Park SI et al (2000) Covered retrievable expandable nitinol stents in patients with benign esophageal strictures: initial experience. Radiology 217:551–557PubMed
8.
go back to reference Koo DH, Park SI, Kim YH et al (2012) Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data. Cancer Chemother Pharmacol 69:655–663 Koo DH, Park SI, Kim YH et al (2012) Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data. Cancer Chemother Pharmacol 69:655–663
9.
go back to reference Burstow M, Kelly T, Panchani S et al (2009) Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis. Dis Esophagus 22:519–525PubMedCrossRef Burstow M, Kelly T, Panchani S et al (2009) Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis. Dis Esophagus 22:519–525PubMedCrossRef
10.
go back to reference Eroglu A, Turkyilmaz A, Subasi M et al (2010) The use of self-expandable metallic stents for palliative treatment of inoperable esophageal cancer. Dis Esophagus 23:64–70 Eroglu A, Turkyilmaz A, Subasi M et al (2010) The use of self-expandable metallic stents for palliative treatment of inoperable esophageal cancer. Dis Esophagus 23:64–70
11.
go back to reference Homs YV, Kuipers EJ, Siersema PD (2005) Palliative therapy. J Surg Oncol 92:246–256 Homs YV, Kuipers EJ, Siersema PD (2005) Palliative therapy. J Surg Oncol 92:246–256
12.
go back to reference Homs YV, Hansen BE, Blankenstein MV et al (2004) Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma. Eur J Gastroenterol Hepatol 16:163–170PubMedCrossRef Homs YV, Hansen BE, Blankenstein MV et al (2004) Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma. Eur J Gastroenterol Hepatol 16:163–170PubMedCrossRef
13.
go back to reference Radecke K, Gerken G, Treichel U (2005) Impact of a self-expanding, plastic esophageal stent on various esophageal stenoses, fistulas, and leakages: a single-center experience in 39 patients. Gastrointest Endosc 61:812–818PubMedCrossRef Radecke K, Gerken G, Treichel U (2005) Impact of a self-expanding, plastic esophageal stent on various esophageal stenoses, fistulas, and leakages: a single-center experience in 39 patients. Gastrointest Endosc 61:812–818PubMedCrossRef
14.
go back to reference Nishimura Y, Suzuki M, Nakamatsu K et al (2002) Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 53:134–139PubMedCrossRef Nishimura Y, Suzuki M, Nakamatsu K et al (2002) Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 53:134–139PubMedCrossRef
Metadata
Title
Temporary stent placement with concurrent chemoradiation therapy in patients with unresectable oesophageal carcinoma: is there an optimal time for stent removal?
Authors
Jung-Hoon Park
Ho-Young Song
Ju Yang Park
Jin Hyoung Kim
Yong Hee Kim
Jong-Hoon Kim
Sung-Bae Kim
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
European Radiology / Issue 7/2013
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-013-2786-1

Other articles of this Issue 7/2013

European Radiology 7/2013 Go to the issue